Related Posts

Why Study Toxic Metals in Infant Formula?
An Overview of the Results
May 2024
Michelle Perro, MD
CEO, GMOScience.org
Article 3 in the Got Real Milk Series
The presence of toxic metals in infant formula is a critical issue that demands immediate action.
Public education is crucial to raise awareness among parents and caregivers about the potential risks and safety measures. Regulatory action by Congress is necessary to empower the FDA and other agencies to enforce stringent safety standards. Additionally, formula companies must take corrective actions to ensure their products are safe.
To address this issue, we are initiating a petition to urge Congress to remove any barriers preventing the FDA from enforcing these necessary regulations. In the meantime, parents can consider various supplements that may help offset the toxicity, although this should be done in consultation with healthcare professionals.
By working together—regulators, companies, and consumers—we can ensure that infant formula products are safe and healthy for our most vulnerable population, our babies.

Toxic Metals in Babies’ Formula Overview:
An Introduction to our Research
April 2024
Michelle Perro, MD
CEO, GMOScience.org
Article 2 in the Got Real Milk Series
Given the critical importance of ensuring the safety of baby food, the involvement of citizen scientists in testing for toxic metals cannot be overstated. Baby food, a primary nutritional source for infants, must be free from contaminants that could impair their health and development. Recent investigations have revealed concerning levels of toxic metals like arsenic, lead, cadmium, aluminum, and mercury in various baby food products. These findings underscore the need for vigilant monitoring.

Genetic Engineering and Babies
ONE-AND-DONE

April 2024

Editorial, CEO, Michelle Perro, MD

Photo Credit Children’s Medical Center www.npcmc.com

Small Interfering RNA (siRNA)

As a children’s specialist, I want to caution parents regarding the emerging use of small interfering RNA (siRNA) technology, particularly in therapeutic contexts potentially applicable to infants and young children. This technology, which manipulates RNA to silence specific genes, is still in its infancy and carries significant unknowns. Early research indicates that siRNA can unintentionally impact off-target genes, leading to unpredictable biological outcomes.